In Switzerland, employers and employees are requested to settle together the amount of risk and priorities for each industrial activity, for the needs of a federal commission in charge of occupational health specialists. After our results, this aim will be difficult to achieve, since the feelings of employers and employees on similar safety problems vary widely. In particular, chemical risks did not evoke similar reactions in employers and employees of the French and of the German-speaking regions. In order to help employers and employees to reach a consensus, a method will be developed in a near future.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF02098316 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The relationship between fatigue, sleep quality, and sleep deprivation.
Sleep Breath
January 2025
Faculty of Medicine, Institute of Health Sciences, Department of Public Health, University of Hacettepe, Ankara, Türkiye.
Background: Fatigue, sleep disorders, and daytime sleepiness are interconnected, posing significant risks to occupational health and workplace safety. However, the literature on their relationships remains fragmented, with notable gaps, particularly concerning working populations. This descriptive cross-sectional study aimed to evaluate sleep quality (SQ), daily sleep time in hours (DST), daytime sleepiness, fatigue levels among employees in an automotive workplace, and their interrelationships.
View Article and Find Full Text PDFNavigating Toxicity: Investigating the Interplay Between Workplace Gaslighting, Workaholism, and Agility Among Nurses.
Nurs Inq
January 2025
Medical Surgical Nursing Department, Faculty of Nursing, Alexandria University, Alexandria, Egypt.
Toxic workplace environments, especially those involving gaslighting, are known to contribute to stress and excessive work habits, such as workaholism, which may hinder a nurse's agility-an essential skill in adapting to fast-paced healthcare environments. However, the interplay between workplace gaslighting, workaholism, and agility in nursing remains underexplored. This study aims to investigate the relationship between workplace gaslighting, workaholism, and agility among nurses, focusing on how gaslighting moderates this relationship.
View Article and Find Full Text PDFExamining the Impact of Digital Detox Interventions on Anxiety and Depression Levels Among Young Adults.
Cureus
December 2024
Clinical Laboratory Sciences, Jouf University, Jouf, SAU.
Background: With increasing reliance on digital devices, concerns about their impact on mental health have grown, particularly among young adults.
Aim: This study aims to evaluate the impact of a digital detox intervention on reducing anxiety and depression among young adults across diverse demographic backgrounds.
Methods: A pre-test, followed by a digital detox intervention, and a post-test using an online survey was carried out.
Developing a Research Center for Artificial Intelligence in Medicine.
Mayo Clin Proc Digit Health
December 2024
Department Radiology, Stanford University, Stanford, CA.
Artificial intelligence (AI) and machine learning (ML) are driving innovation in biosciences and are already affecting key elements of medical scholarship and clinical care. Many schools of medicine are capitalizing on the promise of these new technologies by establishing academic units to catalyze and grow research and innovation in AI/ML. At Stanford University, we have developed a successful model for an AI/ML research center with support from academic leaders, clinical departments, extramural grants, and industry partners.
View Article and Find Full Text PDFBlarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.
J Prev Alzheimers Dis
January 2025
Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA. Electronic address:
Background: There are no approved oral disease-modifying treatments for Alzheimer's disease (AD).
Objectives: The objective of this study was to assess efficacy and safety of blarcamesine (ANAVEX®2-73), an orally available small-molecule activator of the sigma-1 receptor (SIGMAR1) in early AD through restoration of cellular homeostasis including autophagy enhancement.
Design: ANAVEX2-73-AD-004 was a randomized, double-blind, placebo-controlled, 48-week Phase IIb/III trial.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!